Christian Caglevic

1. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
   2019/04/04 by Tony Mok, Tony S K Mok, Yi-Long Wu +283 · 3 citations
   Medicine · #Cancer Immunotherapy and Biomarkers #Lung Cancer Diagnosis and Treatment #Radiomics and Machine Learning in Medical Imaging